Authors: Mohr, DC Boudewyn, AC Likosky, W Levine, E Goodkin, DE

Citation: Dc. Mohr et al., Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject, ANN BEHAV M, 23(2), 2001, pp. 125-132

Authors: Mohr, DC Likosky, W Bertagnolli, A Goodkin, DE Van der Wende, J Dwyer, P Dick, LP

Citation: Dc. Mohr et al., Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis, J CONS CLIN, 68(2), 2000, pp. 356-361

Authors: Mohr, DC Dick, LP Russo, D Likosky, W Pinn, J Boudewyn, AC Goodkin, DE

Citation: Dc. Mohr et al., The psychosocial impact of multiple sclerosis: Exploring the patient's perspective, HEALTH PSYC, 18(4), 1999, pp. 376-382

Authors: Mohr, DC Likosky, W Dwyer, P Van der Wende, J Boudewyn, AC Goodkin, DE

Citation: Dc. Mohr et al., Course of depression during the initiation of interferon beta-1a treatmentfor multiple sclerosis, ARCH NEUROL, 56(10), 1999, pp. 1263-1265

Authors: Mohr, DC Likosky, W Boudewyn, AC Marietta, P Dwyer, P Van Der Wende, J Goodkin, DE

Citation: Dc. Mohr et al., Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a, MULT SCLER, 4(6), 1998, pp. 487-489